{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:49:37Z","timestamp":1790689777594,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurologic.theclinics.com","mdconsult.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ncl.2014.04.010","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T05:21:39Z","timestamp":1405488099000},"page":"751-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Pompe Disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Majed","family":"Dasouki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Jawdat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Almadhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Pasnoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April L.","family":"McVey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abuzinadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Herbelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2014.04.010_bib1","first-page":"304","article-title":"Over idiopatische hypertrophie van het hart","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.ncl.2014.04.010_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/BF02248461","article-title":"Zum klinischen Bild der Glykogen-Speicherungs-Krankheit (Glykogenose)","volume":"52","author":"Bischoff","year":"1932","journal-title":"Z Kinderheilk"},{"key":"10.1016\/j.ncl.2014.04.010_bib3","first-page":"222","article-title":"Uber angeborene Glykogenspeicher-Krankheit des herzens. \u201cThesaurismosis glycogenica\u201d (v. Gierke)","volume":"90","author":"Putschar","year":"1932","journal-title":"Biochem J"},{"key":"10.1016\/j.ncl.2014.04.010_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"alpha-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem J"},{"key":"10.1016\/j.ncl.2014.04.010_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ncl.2014.04.010_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.c.31321","article-title":"Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations","volume":"160C","author":"Case","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"Consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2014.04.010_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: molecular mechanisms and biological functions of autophagy","volume":"6","author":"Levine","year":"2004","journal-title":"Dev Cell"},{"key":"10.1016\/j.ncl.2014.04.010_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2161","article-title":"Unveiling the roles of autophagy in innate and adaptive immunity","volume":"7","author":"Levine","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ncl.2014.04.010_bib10","doi-asserted-by":"crossref","first-page":"ra31","DOI":"10.1126\/scisignal.2000911","article-title":"Ammonia derived from glutaminolysis is a diffusible regulator of autophagy","volume":"3","author":"Eng","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.ncl.2014.04.010_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.1099993","article-title":"Autophagy in health and disease: a double-edged sword","volume":"306","author":"Shintani","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ncl.2014.04.010_bib12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4161\/cc.6.15.4511","article-title":"Autophagy and human disease","volume":"6","author":"Huang","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ncl.2014.04.010_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2014.04.010_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.ncl.2014.04.010_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2013.08.005","article-title":"Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies","volume":"110","author":"Preisler","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.c.31322","article-title":"Toward deconstructing the phenotype of late-onset Pompe disease","volume":"160","author":"Sch\u00fcller","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/mgme.1998.2800","article-title":"Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cells","volume":"66","author":"Meikle","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.ncl.2014.04.010_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI112262","article-title":"Trafficking of lysosomal enzymes in normal and disease states","volume":"77","author":"Kornfeld","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ncl.2014.04.010_bib20","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","article-title":"Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation","volume":"268","author":"Wisselaar","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ncl.2014.04.010_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ncl.2014.04.010_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cccn.2005.04.007","article-title":"Retrospective diagnosis of glycogen storage disease type II by use of a newborn-screening card","volume":"359","author":"Niizawa","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ncl.2014.04.010_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.gim.0000217781.66786.9b","article-title":"Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease","volume":"8","author":"Zhang","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.ncl.2014.04.010_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2013.05.001","article-title":"Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform","volume":"424","author":"Sista","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ncl.2014.04.010_bib25","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1373\/clinchem.2011.164640","article-title":"Simplified newborn screening protocol for lysosomal storage disorders","volume":"57","author":"Metz","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.ncl.2014.04.010_bib26","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1021\/ac200417u","article-title":"Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases","volume":"83","author":"Sp\u00e1\u010dil","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.ncl.2014.04.010_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2012.09.012","article-title":"Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening","volume":"908","author":"Mechtler","year":"2012","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ncl.2014.04.010_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques","volume":"160C","author":"Young","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib29","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1373\/clinchem.2012.201053","article-title":"Oligosaccharide analysis in urine by MALDI-TOF mass spectrometry for the diagnosis of lysosomal storage diseases","volume":"59","author":"Xia","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.ncl.2014.04.010_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2013.08.010","article-title":"A\u00a0new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease","volume":"111","author":"Wang","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1073\/pnas.93.1.65","article-title":"High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease","volume":"93","author":"Van Hove","year":"1996","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2014.04.010_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/01.wnl.0000299892.81127.8e","article-title":"Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency","volume":"70","author":"Nascimbeni","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.04.010_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/jhg.2009.32","article-title":"Structural modeling of mutant alpha-glucosidases resulting in a processing\/transport defect in Pompe disease","volume":"54","author":"Sugawara","year":"2009","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib35","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10038-007-0191-9","article-title":"Structural and biochemical studies on Pompe disease and a \u201cpseudodeficiency of acid alpha-glucosidase.\u201d","volume":"52","author":"Tajima","year":"2007","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2009.03.004","article-title":"High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population","volume":"97","author":"Kumamoto","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib38","unstructured":"Kemper AR. The Condition Review Workgroup. Evidence report: newborn screening for pompe disease. Available at: http:\/\/www.hrsa.gov\/advisorycommittees\/mchbadvisory\/heritabledisorders\/nominatecondition\/reviews\/pompereport2013.pdf. Accessed June 3, 2013."},{"key":"10.1016\/j.ncl.2014.04.010_bib39","unstructured":"Costin-Kelly N. Histological analysis of a muscle biopsy. The biomedical scientist. 2008:1063\u201370."},{"key":"10.1016\/j.ncl.2014.04.010_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1590\/0004-282X20130022","article-title":"Muscle biopsy in Pompe disease","volume":"71","author":"Werneck","year":"2013","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.ncl.2014.04.010_bib41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/2013.jamaneurol.486","article-title":"Diagnosis of Pompe disease: muscle biopsy vs blood-based assays","volume":"70","author":"Vissing","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2014.04.010_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2014.04.010_bib43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1750-1172-8-90","article-title":"Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy","volume":"8","author":"Prater","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ncl.2014.04.010_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mus.21393","article-title":"Diagnostic criteria for late-onset (childhood and adult) Pompe disease","volume":"40","author":"Al-Lozi","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2014.04.010_bib45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-7-88","article-title":"Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study","volume":"7","author":"van der Beek","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ncl.2014.04.010_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2012.12.003","article-title":"Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement","volume":"23","author":"Hobson-Webb","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2014.04.010_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF02906075","article-title":"A\u00a0biochemical and ultrastructural study of liver, muscle, heart and kidney in type II glycogenosis","volume":"4","author":"Bruni","year":"1970","journal-title":"Virchows Arch B Cell Pathol"},{"key":"10.1016\/j.ncl.2014.04.010_bib48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bjo.61.7.476","article-title":"Ocular ultrastructural study in a fetus with type II glycogenosis","volume":"61","author":"Libert","year":"1977","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2014.04.010_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2739\/kurumemedj.26.349","article-title":"An autopsy case of type II glycogenosis","volume":"26","author":"Nakamura","year":"1979","journal-title":"Kurume Med J"},{"key":"10.1016\/j.ncl.2014.04.010_bib50","first-page":"25","article-title":"Ultrastructure of the eye in fetal type II glycogenosis (Pompe's disease)","volume":"22","author":"Pokorny","year":"1982","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ncl.2014.04.010_bib51","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.105.3.947","article-title":"Obstructive sleep apnea syndrome in acid maltase deficiency","volume":"105","author":"Margolis","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.ncl.2014.04.010_bib52","first-page":"379","article-title":"Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings","volume":"27","author":"Teng","year":"2004","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.ncl.2014.04.010_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00404-004-0620-3","article-title":"Prenatal diagnosis of Pompe disease by electron microscopy","volume":"271","author":"Phupong","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ncl.2014.04.010_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2010.01.015","article-title":"Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case","volume":"100","author":"Kobayashi","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib55","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ymgme.2012.05.007","article-title":"Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature","volume":"106","author":"Hobson-Webb","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"issue":"S1","key":"10.1016\/j.ncl.2014.04.010_bib57","first-page":"19","article-title":"Tongue weakness in a patient with myopathy","volume":"14","author":"Zamanifekri","year":"2013","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"key":"10.1016\/j.ncl.2014.04.010_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1172-8-49","article-title":"Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study","volume":"8","author":"G\u00fcng\u00f6r","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ncl.2014.04.010_bib59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","article-title":"Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa","volume":"107","author":"van der Ploeg","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clineuro.2010.12.005","article-title":"Adult Pompe disease: clinical manifestations and outcome of the first Greek patients receiving enzyme replacement therapy","volume":"113","author":"Papadimas","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ncl.2014.04.010_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-7-35","article-title":"A\u00a0cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations","volume":"7","author":"Herzog","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ncl.2014.04.010_bib62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2013.03.016","article-title":"Enzyme replacement therapy and fatigue in adults with Pompe disease","volume":"109","author":"G\u00fcng\u00f6r","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11910-011-0236-5","article-title":"Enzyme replacement therapy for Pompe disease","volume":"12","author":"Angelini","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ncl.2014.04.010_bib64","first-page":"951","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2014.04.010_bib65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.ncl.2014.04.010_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mus.23659","article-title":"Basilar artery aneurysm: a new finding in classic infantile Pompe disease","volume":"47","author":"Patel","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2014.04.010_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ymgme.2011.04.009","article-title":"Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered","volume":"103","author":"El-Gharbawy","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib68","first-page":"96","article-title":"Progress and problems in muscle glycogenoses","volume":"30","author":"DiMauro","year":"2011","journal-title":"Acta Myol"},{"key":"10.1016\/j.ncl.2014.04.010_bib69","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/WCO.0b013e328364dbdc","article-title":"New insights in the field of muscle glycogenoses","volume":"26","author":"Oldfors","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2014.04.010_bib70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1750-3639.2011.00543.x","article-title":"Autophagy in lysosomal myopathies","volume":"22","author":"Malicdan","year":"2012","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ncl.2014.04.010_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajmg.c.31317","article-title":"Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten","volume":"160C","author":"Raben","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib72","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-8417-1-6","article-title":"Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts","volume":"1","author":"Cardone","year":"2008","journal-title":"Pathogenetics"},{"key":"10.1016\/j.ncl.2014.04.010_bib73","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.20807","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease","volume":"59","author":"Fukuda","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2014.04.010_bib74","doi-asserted-by":"crossref","first-page":"e56825","DOI":"10.1371\/journal.pone.0056825","article-title":"A\u00a0nonsense mutation in the acid \u03b1-glucosidase gene causes Pompe disease in Finnish and Swedish Lapphunds","volume":"8","author":"Sepp\u00e4l\u00e4","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2014.04.010_bib75","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature03029","article-title":"The role of autophagy during the early neonatal starvation period","volume":"432","author":"Kuma","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2014.04.010_bib76","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200412022","article-title":"Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice","volume":"169","author":"Komatsu","year":"2005","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.ncl.2014.04.010_bib77","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.ncl.2014.04.010_bib78","first-page":"233","article-title":"Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations","volume":"43","author":"Engel","year":"1968","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2014.04.010_bib79","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/brain\/93.3.599","article-title":"Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies","volume":"93","author":"Engel","year":"1970","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2014.04.010_bib80","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4161\/auto.21691","article-title":"Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients","volume":"8","author":"Nascimbeni","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.ncl.2014.04.010_bib81","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ymgme.2012.09.011","article-title":"Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease","volume":"107","author":"Nishiyama","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib82","doi-asserted-by":"crossref","first-page":"e56181","DOI":"10.1371\/journal.pone.0056181","article-title":"Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease","volume":"8","author":"Taylor","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2014.04.010_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0960-8966(02)00186-4","article-title":"Effect of acid maltase deficiency on the endosomal\/lysosomal system and glucose transporter 4","volume":"13","author":"Orth","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2014.04.010_bib85","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaneurol.2013.1507","article-title":"Systemic metabolic abnormalities in adult-onset acid maltase deficiency: beyond muscle glycogen accumulation","volume":"70","author":"Pascual","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2014.04.010_bib86","first-page":"281","article-title":"Principles and practice of mass screening for disease","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"key":"10.1016\/j.ncl.2014.04.010_bib87","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ncl.2014.04.010_bib88","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.cca.2012.04.012","article-title":"Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: application to a small-scale population study for five lysosomal storage disorders","volume":"413","author":"Orsini","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ncl.2014.04.010_bib89","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.c.31315","article-title":"Newborn screening for Pompe disease: an update, 2011","volume":"160C","author":"Burton","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib90","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jpeds.2010.11.053","article-title":"Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening","volume":"158","author":"Chien","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ncl.2014.04.010_bib91","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","article-title":"Algorithm for Pompe disease newborn screening: results from the Taiwan screening program","volume":"106","author":"Chiang","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib92","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ymgme.2011.09.002","article-title":"Newborn screening for Pompe disease in Japan","volume":"104","author":"Oda","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib93","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.cca.2012.07.011","article-title":"First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene","volume":"413","author":"Paciotti","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ncl.2014.04.010_bib94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2012_130","article-title":"Newborn screening for lysosomal storage disorders in Hungary","volume":"6","author":"Wittmann","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ncl.2014.04.010_bib95","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clinbiochem.2011.03.008","article-title":"Dried blood spots in the diagnosis of lysosomal storage disorders\u2013possibilities for newborn screening and high-risk population screening","volume":"44","author":"Lukacs","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ncl.2014.04.010_bib96","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/8904_2013_229","article-title":"Selective screening for lysosomal storage diseases with dried blood spots collected on filter paper in 4,700 high-risk Colombian subjects","volume":"11","author":"Uribe","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ncl.2014.04.010_bib97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","article-title":"Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria","volume":"379","author":"Mechtler","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2014.04.010_bib98","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10545-011-9435-0","article-title":"Newborn screening for lysosomal storage diseases: an ethical and policy analysis","volume":"35","author":"Ross","year":"2012","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.ncl.2014.04.010_bib99","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2012.04.027","article-title":"The impact of antibodies in late-onset Pompe disease: a case series and literature review","volume":"106","author":"Patel","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ymgme.2011.09.012","article-title":"First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease","volume":"104","author":"de Vries","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib101","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nmd.2012.11.006","article-title":"Pregnancy during enzyme replacement therapy for late-onset acid maltase deficiency","volume":"23","author":"Zagnoli","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2014.04.010_bib102","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/gim.2011.4","article-title":"Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease","volume":"14","author":"Messinger","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.ncl.2014.04.010_bib103","doi-asserted-by":"crossref","first-page":"e67052","DOI":"10.1371\/journal.pone.0067052","article-title":"Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT","volume":"8","author":"Banugaria","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2014.04.010_bib104","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib105","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/0883073813485819","article-title":"Immune tolerance induced using plasma exchange and rituximab in an infantile Pompe disease patient","volume":"29","author":"Deodato","year":"2013","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.ncl.2014.04.010_bib106","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jpeds.2013.03.002","article-title":"B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease","volume":"163","author":"Elder","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ncl.2014.04.010_bib107","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/GIM.0b013e318211a7e1","article-title":"Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals","volume":"13","author":"Wang","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.ncl.2014.04.010_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","article-title":"Pompe disease: design, methodology, and early findings from the Pompe Registry","volume":"103","author":"Byrne","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib109","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ymgme.2011.08.011","article-title":"The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe Registry","volume":"104","author":"Roberts","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ncl.2014.04.010_bib110","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","volume":"161","author":"Kishnani","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ncl.2014.04.010_bib111","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/8904_2011_25","article-title":"Utility of rare disease registries in Latin America","volume":"1","author":"Martins","year":"2011","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ncl.2014.04.010_bib112","first-page":"2279","article-title":"Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease","volume":"260","author":"Hundsberger","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2014.04.010_bib113","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neurol.2013.07.002","article-title":"The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease","volume":"169","author":"Lafor\u00eat","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.ncl.2014.04.010_bib114","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1212\/WNL.0b013e3182553c11","article-title":"Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy","volume":"78","author":"Ebbink","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.04.010_bib115","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1074\/jbc.M112.438663","article-title":"Glycosylation-independent lysosomal targeting of acid \u03b1-glucosidase enhances muscle glycogen clearance in Pompe mice","volume":"288","author":"Maga","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ncl.2014.04.010_bib116","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.nano.2011.08.014","article-title":"Enhanced delivery of \u03b1-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders","volume":"8","author":"Hsu","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ncl.2014.04.010_bib117","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/BJ20050364","article-title":"Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice","volume":"389","author":"Zhu","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.ncl.2014.04.010_bib118","doi-asserted-by":"crossref","first-page":"e40776","DOI":"10.1371\/journal.pone.0040776","article-title":"The pharmacological chaperone AT2220 increases recombinant human acid \u03b1-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease","volume":"7","author":"Khanna","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2014.04.010_bib119","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/humu.21121","article-title":"The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase","volume":"30","author":"Flanagan","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ncl.2014.04.010_bib120","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"Porto","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.ncl.2014.04.010_bib121","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nbt.2427","article-title":"A\u00a0bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes","volume":"30","author":"Tiels","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ncl.2014.04.010_bib122","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/iub.529","article-title":"New insights into therapeutic options for Pompe disease","volume":"63","author":"Richard","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ncl.2014.04.010_bib123","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1093\/hmg\/ddn292","article-title":"Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease","volume":"17","author":"Raben","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib124","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","article-title":"Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder\u2013murine Pompe disease","volume":"6","author":"Raben","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ncl.2014.04.010_bib125","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/sj.gt.3302096","article-title":"Correction\/mutation of acid alpha-D-glucosidase gene by modified single-stranded oligonucleotides: in\u00a0vitro and in\u00a0vivo studies","volume":"10","author":"Lu","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.ncl.2014.04.010_bib126","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1093\/hmg\/ddn290","article-title":"Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II","volume":"17","author":"Douillard-Guilloux","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib127","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4161\/auto.24920","article-title":"What else is in store for autophagy? Exocytosis of autolysosomes as a mechanism of TFEB-mediated cellular clearance in Pompe disease","volume":"9","author":"Feeney","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.ncl.2014.04.010_bib128","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/emmm.201202176","article-title":"Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease","volume":"5","author":"Spampanato","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ncl.2014.04.010_bib129","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1093\/hmg\/ddr174","article-title":"Pompe disease gene therapy","volume":"20","author":"Byrne","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2014.04.010_bib130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/mt.2011.214","article-title":"Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice","volume":"20","author":"Qiu","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.ncl.2014.04.010_bib131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/humc.2013.147","article-title":"Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid \u03b1-glucosidase","volume":"24","author":"Conlon","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.ncl.2014.04.010_bib132","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jgm.1305","article-title":"Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease","volume":"11","author":"Douillard-Guilloux","year":"2009","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.ncl.2014.04.010_bib133","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1182\/blood-2009-11-252874","article-title":"Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype","volume":"115","author":"van Til","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ncl.2014.04.010_bib134","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2011.05.020","article-title":"Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells","volume":"104","author":"Kawagoe","year":"2011","journal-title":"Mol Genet Metab"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T05:11:55Z","timestamp":1717045915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861914000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0733861914000334"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2014.04.010","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pompe Disease","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2014.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}